Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CSF proteomic study of Alzheimer's Disease

ABSTRACT: TMT Proteomic study of CSF from patients with Alzheimer's disease, non-cognitively impaired controls, and subjects with mild or subjective cognitive impairment

INSTRUMENT(S): Orbitrap Fusion

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Johan Gobom

PROVIDER: MSV000098527 | MassIVE | Tue Jul 15 10:41:00 BST 2025

SECONDARY ACCESSION(S): PXD019910

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

CSF proteomic study of Alzheimer's Disease

Project description:TMT Proteomic study of CSF from patients with Alzheimer's disease, non-cognitively impaired controls, and subjects with mild or subjective cognitive impairment

2020-12-04 | PXD019910 | Pride

microRNA microarray profile in the plasma of mild cognitive impairment due to Alzheimer's disease

Project description:To explore the microRNAs associated with pathology of early Alzheimer's disease, we detected the microRNA profiles in the plasma of subjects with mild cognitive impairment due to Alzheimer's disease and gender-, age-, education-matched normal control elderly.

2020-03-20 | GSE147232 | GEO

Long noncoding RNA microarray profile in the plasma of mild cognitive impairment due to Alzheimer's disease

Project description:To explore the lncRNAs associated with pathology of early Alzheimer's disease, we detected the lncRNA profiles in the plasma of subjects with mild cognitive impairment due to Alzheimer's disease and gender-, age-, education-matched normal control elderly.

2023-03-01 | GSE225304 | GEO

Subgingival microbiota in Alzheimer's disease

Project description:The subgingival microbiome in Alzheimer's disease, mild cognitive impairment and subjective cognitive decline

| PRJEB35923 | ENA

Alzheimer, MCI and control samples from AddneuroMed Cohort (batch 1)

Project description:Alzheimer case-control samples originate from the EU funded AddNeuroMed Cohort, which is a large cross-European AD biomarker study relying on human blood as the source of RNA. The design is case-control. Cases are either Alzheimer's disease patients, subjects with mild cognitive impairment or age and gender matched controls.

2015-08-05 | E-GEOD-63060 | biostudies-arrayexpress

Alzheimer, Mild Cognitive impairment and control samples from AddneuroMed Cohort (batch 2)

2015-08-05 | E-GEOD-63061 | biostudies-arrayexpress

scRNAseq + scV(D)J of cerebrospinal fluid samples across age

Project description:Cerebrospinal fluid (CSF) contains a tightly regulated, specialized immune system. Yet, little is known about how aging influences CSF immunity in cognitively typical versus cognitively impaired individuals. Here, we performed single cell RNA sequencing (scRNAseq) on CSF collected from 45 cognitively typical subjects ranging from 54-82 years old. We then assessed age-related transcriptomic changes using several bioinformatic approaches, including linear and local polynomial regression. We reveal pronounced changes to several CSF immune cell types that occur around age 75, including alterations to clonally expanded T cells and activated monocytes. We then compared CSF immune systems from cognitively typical subjects to 14 subjects with mild cognitive impairment or Alzheimer’s disease. Our results indicate disparate age-related CSF immune system perturbations in cognitively impaired subjects. These results highlight the potential to utilize CSF immune changes to identify age-related neuroinflammation in cognitively impaired individuals.

2022-12-12 | GSE200164 | GEO

AD patients plasma exosome miRNA sequencing

Project description:The experiment is for demonstrating the miRNA profiles in plasma exosomes derived from mild cognitive impairment and Alzheimer's disease patients and healthy donors.

2022-01-30 | E-MTAB-11222 | biostudies-arrayexpress

Transcriptomic predictors of rapid progression from mild cognitive impairment to Alzheimer's Disease

Project description:Transcriptomic predictors of rapid progression from mild cognitive impairment to Alzheimer's Disease

| PRJNA1190346 | ENA

Characterization of Global DNA Methylome in Mild Cognitive Impairment and Alzheimer's Disease

Project description:Characterization of Global DNA Methylome in Mild Cognitive Impairment and Alzheimer's Disease

| PRJNA860378 | ENA